the MiMedx





MiMedx offers the largest selection of placental-based allografts to meet the needs of patients and providers.

Learn more about our recently published multicenter diabetic foot ulcer randomized controlled trials on EpiFix® and EpiCord®:

  • Subjects treated with EpiFix were more than twice as likely to heal completely within 12 weeks as those not receiving EpiFix 1.
  • EpiCord patients were significantly more likely to completely heal compared to control 2.

Questions? Call 888.543.1917 or Contact Us